Open Access 25-03-2025 | Stroke | Review Article

Autonomic dysfunction after stroke: an overview of recent clinical evidence and perspectives on therapeutic management

Authors: Anush Barkhudaryan, Wolfram Doehner, Nadja Jauert

Published in: Clinical Autonomic Research

Abstract

Purpose

Central autonomic dysfunction is common in acute stroke and is associated with cardiovascular complications and increased mortality. The aim of this review is to present novel diagnostic and therapeutic approaches to the management of this disorder and the latest data on its impact on the clinical outcome after stroke.

Methods

We performed a narrative review of recent literature, with a particular focus on articles related to underlying pathophysiological mechanisms of cardiac autonomic dysregulation, the role of cardiac autonomic dysregulation in the activation of neuroinflammatory response and the development of cardiovascular, respiratory and metabolic complications in patients with ischemic and hemorrhagic stroke.

Results

The assessment of central autonomic dysfunction by non-invasive diagnostic techniques, including heart rate variability and baroreflex sensitivity, has gained wide practical application in recent years, and they may have a predictive role for evaluating disease prognosis. The emerging evidence derived from recent trials demonstrates that the presence of autonomic imbalance may lead to increased mortality and have an adverse effect on post-stroke rehabilitation.

Conclusion

The early detection and treatment of central autonomic system dysfunction may lead to improved survival of patients with stroke. Among the available therapeutic approaches, neuromodulatory techniques and pharmacological interventions are promising strategies which may be implemented as part of standard acute stroke care to improve patient recovery. Future studies are warranted to address the long-term effects of potential therapeutic agents on the modulation of cardiovascular autonomic function in stroke survivors.

GBD 2021 Diseases and Injuries Collaborators (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024(403):2133–2161. https://doi.org/10.1016/S0140-6736(24)00757-8CrossRef

Benarroch EE (2020) Physiology and pathophysiology of the autonomic nervous system. Continuum (Minneap Minn) 26:12–24. https://doi.org/10.1212/CON.0000000000000817CrossRefPubMed

Kaufmann H, Norcliffe-Kaufmann L, Palma J (2020) Baroreflex dysfunction. N Engl J Med 382:163–178. https://doi.org/10.1056/NEJMra1509723CrossRefPubMed

Nayani S, Sreedharan SE, Namboodiri N, Sarma PS, Sylaja PN (2016) Autonomic dysfunction in first ever ischemic stroke: prevalence, predictors and short term neurovascular outcome. Clin Neurol Neurosurg 150:54–58. https://doi.org/10.1016/j.clineuro.2016.08.022CrossRefPubMed

Xiong L, Tian G, Leung H et al (2018) Autonomic dysfunction predicts clinical outcomes after acute ischemic stroke: a prospective observational study. Stroke 49:215–218. https://doi.org/10.1161/STROKEAHA.117.019312CrossRefPubMed

Damkjær M, Simonsen SA, Heiberg AV et al (2023) Autonomic dysfunction after mild acute ischemic stroke and six months after: a prospective observational cohort study. BMC Neurol 23:26. https://doi.org/10.1186/s12883-023-03054-4CrossRefPubMedPubMedCentral

Sposato LA, Hilz MJ, Aspberg S et al (2020) Post-stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review. J Am Coll Cardiol 76:2768–2785. https://doi.org/10.1016/j.jacc.2020.10.009CrossRefPubMed

Du Y, Demillard LJ, Ren J (2021) Catecholamine-induced cardiotoxicity: a critical element in the pathophysiology of stroke-induced heart injury. Life Sci 287:120106. https://doi.org/10.1016/j.lfs.2021.120106CrossRefPubMed

Dorrance AM, Fink G (2015) Effects of stroke on the autonomic nervous system. Compr Physiol 5:1241–1263. https://doi.org/10.1002/cphy.c140016CrossRefPubMed

10.

Chen X, Shi S, Hu L et al (2022) Longitudinal changes in the hypothalamic-pituitary-adrenal axis and sympathetic nervous system are related to the prognosis of stroke. Front Neurol 13:946593. https://doi.org/10.3389/fneur.2022.946593CrossRefPubMedPubMedCentral

11.

Noack C, Heußer K, Tank J et al (2015) Upregulation of muscle sympathetic nerve activity in acute ischemic middle cerebral artery infarction is a risk factor for bacterial infection after stroke. Auton Neurosci Basic Clin 192:35. https://doi.org/10.1016/j.autneu.2015.07.360CrossRef

12.

Lima-Seolin BG, Nemec-Bakk A, Forsyth H et al (2019) Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine. Oxid Med Cell Longev 2019:6325424. https://doi.org/10.1155/2019/6325424CrossRefPubMedPubMedCentral

13.

Lymperopoulos A, Rengo G, Koch WJ (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113:739–753. https://doi.org/10.1161/CIRCRESAHA.113.300308CrossRefPubMed

14.

Jimenez-Ruiz A, Racosta JM, Kimpinski K et al (2021) Cardiovascular autonomic dysfunction after stroke. Neurol Sci 42:1751–1758. https://doi.org/10.1007/s10072-021-05128-yCrossRefPubMed

15.

Mo J, Huang L, Peng J, Ocak U, Zhang J, Zhang JH (2019) Autonomic disturbances in acute cerebrovascular disease. Neurosci Bull 35:133–144. https://doi.org/10.1007/s12264-018-0299-2CrossRefPubMed

16.

Hilz MJ, Moeller S, Akhundova A et al (2011) High NIHSS values predict impairment of cardiovascular autonomic control. Stroke 42:1528–1533. https://doi.org/10.1161/STROKEAHA.110.607721CrossRefPubMed

17.

Grilletti JVF, Scapini KB, Bernardes N et al (2018) Impaired baroreflex sensitivity and increased systolic blood pressure variability in chronic post-ischemic stroke. Clinics (Sao Paulo) 73:e253. https://doi.org/10.6061/clinics/2018/e253CrossRefPubMed

18.

Barra de la Tremblaye P, Plamondon H (2016) Alterations in the corticotropin-releasing hormone (CRH) neurocircuitry: insights into post stroke functional impairments. Front Neuroendocrinol 42:53–75. https://doi.org/10.1016/j.yfrne.2016.07.001CrossRefPubMed

19.

Liesz A, Rüger H, Purrucker J et al (2013) Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS ONE 8:e74839. https://doi.org/10.1371/journal.pone.0074839CrossRefPubMedPubMedCentral

20.

Fontes MAP, Dos Santos Machado LR, Viana ACR et al (2024) The insular cortex, autonomic asymmetry and cardiovascular control: looking at the right side of stroke. Clin Auton Res 34:549–560. https://doi.org/10.1007/s10286-024-01066-9CrossRefPubMed

21.

Méloux A, Béjot Y, Rochette L, Cottin Y, Vergely C (2020) Brain-heart interactions during ischemic processes: clinical and experimental evidences. Stroke 51:679–686. https://doi.org/10.1161/STROKEAHA.119.027732CrossRefPubMed

22.

Chouchou F, Mauguière F, Vallayer O et al (2019) How the insula speaks to the heart: cardiac responses to insular stimulation in humans. Hum Brain Mapp 40:2611–2622. https://doi.org/10.1002/hbm.24548CrossRefPubMedPubMedCentral

23.

Seifert HA, Hall AA, Chapman C et al (2012) A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol 7:1017–1024. https://doi.org/10.1007/s11481-012-9406-8CrossRefPubMedPubMedCentral

24.

Courties G, Herisson F, Sager HB et al (2015) Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res 116:407–417. https://doi.org/10.1161/CIRCRESAHA.116.305207CrossRefPubMed

25.

Simats A, Liesz A (2022) Systemic inflammation after stroke: implications for post-stroke comorbidities. EMBO Mol Med 14:e16269. https://doi.org/10.15252/emmm.202216269CrossRefPubMedPubMedCentral

26.

Iadecola C, Buckwalter MS, Anrather J (2020) Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest 130:2777–2788. https://doi.org/10.1172/JCI135530CrossRefPubMedPubMedCentral

27.

Samary CS, Pelosi P, Leme Silva P, Rocco PRM (2016) Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy. Crit Care 20:391. https://doi.org/10.1186/s13054-016-1573-1CrossRef

28.

Battaglini D, Robba C, Lopes da Silva A et al (2020) Brain-heart interaction after acute ischemic stroke. Crit Care 24:1–2. https://doi.org/10.1186/s13054-020-02885-8CrossRef

29.

Zhou Y, Wang Y, Wang J, Stetler Anne R, Yang QW (2014) Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 115:25–44. https://doi.org/10.1016/j.pneurobio.2013.11.003CrossRefPubMed

30.

Alsbrook DL, Di Napoli M, Bhatia K et al (2023) Neuroinflammation in acute ischemic and hemorrhagic stroke. Curr Neurol Neurosci Rep 23:407–431. https://doi.org/10.1007/s11910-023-01282-2CrossRefPubMedPubMedCentral

31.

Alen NV (2022) The cholinergic anti-inflammatory pathway in humans: state-of-the-art review and future directions. Neurosci Biobehav Rev 136:104622. https://doi.org/10.1016/j.neubiorev.2022.104622CrossRefPubMed

32.

Montuoro S, Gentile F, Giannoni A (2024) Neuroimmune cross-talk in heart failure. Cardiovasc Res. https://doi.org/10.1093/cvr/cvae236CrossRefPubMed

33.

Maisel AS, Knowlton KU, Fowler P et al (1990) Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest 85:462–467. https://doi.org/10.1172/JCI114460CrossRefPubMedPubMedCentral

34.

Scheitz JF, Nolte CH, Doehner W, Hachinski V, Endres M (2018) Stroke-heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol 18:1109–1120. https://doi.org/10.1016/S1474-4422(18)30336-3CrossRef

35.

Kallmunzer B, Breuer L, Kahl N et al (2012) Serious cardiac arrhythmias after stroke: incidence, time course, and predictors–a systematic, prospective analysis. Stroke 43:2892–2897. https://doi.org/10.1161/STROKEAHA.112.664318CrossRefPubMed

36.

Zhang Y, Ouyang M, Qiu J et al (2022) Prognostic value of serum cardiac troponin in acute ischemic stroke: an updated systematic review and meta-analysis. J Stroke Cerebrovasc Dis 31:106444. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.10CrossRefPubMed

37.

Stone J, Mor-Avi V, Ardelt A, Lang RM (2018) Frequency of inverted electrocardiographic T waves (cerebral T waves) in patients with acute strokes and their relation to left ventricular wall motion abnormalities. Am J Cardiol 121:120–124. https://doi.org/10.1016/j.amjcard.2017.09.025CrossRefPubMed

38.

Krause T, Werner K, Fiebach JB et al (2017) Stroke in right dorsal anterior insular cortex is related to myocardial injury. Ann Neurol 81:502–511. https://doi.org/10.1002/ana.24906CrossRefPubMed

39.

Winder K, Millar CV, Siedler G et al (2023) Acute right insular ischaemic lesions and poststroke left ventricular dysfunction. Stroke Vasc Neurol 8:301–306. https://doi.org/10.1136/svn-2022-001724CrossRefPubMedPubMedCentral

40.

Blanc C, Zeller M, Cottin Y et al (2015) Takotsubo cardiomyopathy following acute cerebral events. Eur Neurol 74:163–168. https://doi.org/10.1159/000440717CrossRefPubMed

41.

Scheitz JF, Nolte C, Doehner W, Hachinski V, Endres M (2018) Stroke–heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol 17:1109–1120. https://doi.org/10.1016/S1474-4422(18)30336-3CrossRefPubMed

42.

Wagner S, Güthe T, Bhogal P et al (2021) Aneurysmal subarachnoid hemorrhage as a trigger for Takotsubo syndrome: a comprehensive review. Rev Cardiovasc Med 22:1241–1251. https://doi.org/10.31083/j.rcm2204132CrossRefPubMed

43.

Canavero I, Rifino N, Bussotti M et al (2022) The octopus trap of Takotsubo and stroke: genetics biomarkers and clinical management. J Pers Med 12:1244. https://doi.org/10.3390/jpm12081244CrossRefPubMedPubMedCentral

44.

Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938CrossRefPubMed

45.

Wang YY, Lin SY, Chuang YH et al (2014) Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats. Endocrinology 155:1235–1246. https://doi.org/10.1210/en.2013-1593CrossRefPubMed

46.

Yoon JA, Shin YI, Kim DY et al (2021) Post-stroke hyperglycemia in non-diabetic ischemic stroke is related with worse functional outcome: a cohort study. Ann Rehabil Med 45:359–367. https://doi.org/10.5535/arm.21124CrossRefPubMedPubMedCentral

47.

Mi D, Li Z, Gu H et al (2022) Stress hyperglycemia is associated with in-hospital mortality in patients with diabetes and acute ischemic stroke. CNS Neurosci Ther 28:372–381. https://doi.org/10.1111/cns.13764CrossRefPubMedPubMedCentral

48.

Fraczek MM, Gackowski A, Przybylik-Mazurek E, Nessler J (2016) The relation between the low T3 syndrome in the clinical course of myocardial infarction and heart failure. Pol Merkur Lekarski 40:380–383PubMed

49.

Sidorov E, Paul A, Xu C et al (2023) Decrease of thyroid function after ischemic stroke is related to stroke severity. Thyroid Res 16:28. https://doi.org/10.1186/s13044-023-00160-wCrossRefPubMedPubMedCentral

50.

Gkantzios A, Karapepera V, Tsiptsios D et al (2023) Investigating the predictive value of thyroid hormone levels for stroke prognosis. Neurol Int 15:926–953. https://doi.org/10.3390/neurolint15030060CrossRefPubMedPubMedCentral

51.

Silva De, Anne D et al (2022) Long-term post-stroke functional outcomes: a comparison of diabetics and nondiabetics. Cerebrovasc Dis Extra 12:7–13. https://doi.org/10.1159/000521442CrossRefPubMed

52.

Tan C, Wang Z, Zheng M, Zhao S, Shichinohe H, Houkin K (2021) Responses of immune organs following cerebral ischemic stroke. J Nippon Med Sch 88:228–237. https://doi.org/10.1272/jnms.JNMS.2021_88-308CrossRefPubMed

53.

Jiang Y, Yabluchanskiy A, Deng J et al (2022) The role of age-associated autonomic dysfunction in inflammation and endothelial dysfunction. GeroScience 44:2655–2670. https://doi.org/10.1007/s11357-022-00616-1CrossRefPubMedPubMedCentral

54.

Wang Y, Anesi J, Maier M et al (2023) Sympathetic nervous system and atherosclerosis. Int J Mol Sci 24:13132. https://doi.org/10.3390/ijms241713132CrossRefPubMedPubMedCentral

55.

García L, de Lomana A, Vilhjálmsson A et al (2022) Metabolic response in endothelial cells to catecholamine stimulation associated with increased vascular permeability. Int J Mol Sci 23:3162. https://doi.org/10.3390/ijms23063162CrossRef

56.

Filchenko I, Mürner N, Dekkers MPJ et al (2023) Blood pressure variability, nocturnal heart rate variability and endothelial function predict recurrent cerebro-cardiovascular events following ischemic stroke. Front Cardiovasc Med 10:1288109. https://doi.org/10.3389/fcvm.2023.1288109CrossRefPubMedPubMedCentral

57.

Seiler A, Camilo M, Korostovtseva L et al (2019) Prevalence of sleep-disordered breathing after stroke and TIA: a meta-analysis. Neurology 92:e648–e654. https://doi.org/10.1212/WNL.0000000000006904CrossRefPubMed

58.

Blissitt PA (2017) Sleep-disordered breathing after stroke: nursing implications. Stroke 48:e81–e84. https://doi.org/10.1161/STROKEAHA.116.01308CrossRefPubMed

59.

Baillieul S, Dekkers M, Brill AK et al (2022) Sleep apnoea and ischaemic stroke: current knowledge and future directions. Lancet Neurol 21:78e88. https://doi.org/10.1016/S1474-4422(21)00321-5CrossRef

60.

Scherbakov N, Sandek A, Ebner N et al (2017) Sleep-disordered breathing in acute ischemic stroke: a mechanistic link to peripheral endothelial dysfunction. J Am Heart Assoc 6:e006010. https://doi.org/10.1161/JAHA.117.006010CrossRefPubMedPubMedCentral

61.

Toh ZA, Cheng LJ, Wu XV et al (2023) Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression. Eur Respir Rev 32:220169. https://doi.org/10.1183/16000617.0169-2022CrossRefPubMedPubMedCentral

62.

Bassetti C, Randerath W, Vignatelli L et al (2020) EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur Resp J 55:1901104. https://doi.org/10.1183/13993003.01104-2019CrossRef

63.

64.

Plomaritis P, Theodorou A, Lourentzos K et al (2023) Sleep-disordered breathing in acute stroke: a single-center, prospective, longitudinal study. J Clin Med 12:986. https://doi.org/10.3390/jcm12030986CrossRefPubMedPubMedCentral

65.

Schütz S, Lisabeth L, Hsu C, Kim S, Chervin R, Brown D (2021) Central sleep apnea is uncommon after stroke. Sleep Med 77:304–306. https://doi.org/10.1016/j.sleep.2020.08.025CrossRefPubMed

66.

Huhtakangas J, Saaresranta T, Vähänikkilä H, Huhtakangas J (2022) Nocturnal hypoxemia and central apneas increase mortality, but not recurrent ischemic events after ischemic stroke. Sleep Med 97:1–9. https://doi.org/10.1016/j.sleep.2022.05.014CrossRefPubMed

67.

Kang K, Shi K, Liu J et al (2024) Autonomic dysfunction and treatment strategies in intracerebral hemorrhage. CNS Neurosci Ther 30:e14544. https://doi.org/10.1111/cns.14544CrossRefPubMedPubMedCentral

68.

Al-Qudah ZA, Yacoub HA, Souayah N (2015) Disorders of the autonomic nervous system after hemispheric cerebrovascular disorders: an update. J Vasc Interv Neurol 8:43–52PubMedPubMedCentral

69.

Sykora M, Siarnik P, Szabo J et al (2019) Baroreflex sensitivity is associated with post-stroke infections. An open, prospective study. J Neurol Sci 406:116450. https://doi.org/10.1016/j.jns.2019.116450CrossRefPubMed

70.

Tang S, Xiong L, Fan Y, Mok VCT, Wong KS, Leung TW (2020) Stroke outcome prediction by blood pressure variability, heart rate variability, and baroreflex sensitivity. Stroke 51:1317–1320. https://doi.org/10.1161/STROKEAHA.119.027981CrossRefPubMed

71.

Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381. https://doi.org/10.1161/01.CIR.93.5.1043

72.

Zhao M, Guan L, Wang Y (2020) The association of autonomic nervous system function with ischemic stroke, and treatment strategies. Front Neurol 10:1411. https://doi.org/10.3389/fneur.2019.01411CrossRefPubMedPubMedCentral

73.

Carandina A, Lazzeri G, Villa D et al (2021) Targeting the autonomic nervous system for risk stratification, outcome prediction and neuromodulation in ischemic stroke. Int J Mol Sci 22:2357. https://doi.org/10.3390/ijms22052357CrossRefPubMedPubMedCentral

74.

Guan L, Collet JP, Mazowita G, Claydon VE (2018) Autonomic nervous system and stress to predict secondary ischemic events after transient ischemic attack or minor stroke: possible implications of heart rate variability. Front Neurol 9:90. https://doi.org/10.3389/fneur.2018.00090CrossRefPubMedPubMedCentral

75.

Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Front Public Health 5:258. https://doi.org/10.3389/fpubh.2017.00258CrossRefPubMedPubMedCentral

76.

Scherbakov N, Barkhudaryan A, Ebner N et al (2020) Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome. ESC Heart Failure 7:2983–2991. https://doi.org/10.1002/ehf2.12917CrossRefPubMedPubMedCentral

77.

Buratti L, Cruciani C, Pulcini A et al (2020) Lacunar stroke and heart rate variability during sleep. Sleep Med 73:23–28. https://doi.org/10.1016/j.sleep.2020.04.005CrossRefPubMed

78.

Yperzeele L, van Hooff RJ, Nagels G, De Smedt A, De Keyser J, Brouns R (2015) Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review. Int J Stroke 10:796–800. https://doi.org/10.1111/ijs.12573CrossRefPubMed

79.

Tang S (2015) Complexity of heart rate variability predicts outcome in intensive care unit admitted patients with acute stroke. J Neurol Neurosurg Psychiatry 86:95–100. https://doi.org/10.1136/jnnp-2014-308389CrossRefPubMed

80.

Chidambaram H, Gnanamoorthy K, Suthakaran PK et al (2017) Assessment of autonomic dysfunction in acute stroke patients at a tertiary care hospital. J Clin Diagn Res 11:OC28–OC31. https://doi.org/10.7860/JCDR/2017/24740.9431CrossRefPubMedPubMedCentral

81.

Aftyka J, Staszewski J, Dębiec A et al (2023) Heart rate variability as a predictor of stroke course, functional outcome, and medical complications: a systematic review. Front Physiol 14:1115164. https://doi.org/10.3389/fphys.2023.1115164CrossRefPubMedPubMedCentral

82.

Sammito S, Thielmann B, Böckelmann I (2024) Update: factors influencing heart rate variability-a narrative review. Front Physiol 15:1430458. https://doi.org/10.3389/fphys.2024.1430458CrossRefPubMedPubMedCentral

83.

Biaggioni I, Shibao CA, Diedrich A et al (2019) Blood pressure management in afferent baroreflex failure: JACC review topic of the week. JACC 74:2939–2947. https://doi.org/10.1016/j.jacc.2019.10.027CrossRefPubMed

84.

Celovská D, Stasko J, Gonsorcik J, Diab A (2010) The significance of baroreflex sensitivity in hypertensive subjects with stroke. Physiol Res 59:537–543CrossRefPubMed

85.

Forstenpointner J, Maallo AM, Elman I et al (2022) The solitary nucleus connectivity to key autonomic regions in humans. Eur J Neurosci 56:3938–3966. https://doi.org/10.1111/ejn.15691CrossRefPubMed

86.

Grilletti JV, Scapini KB, Bernardes N et al (2018) Impaired baroreflex sensitivity and increased systolic blood pressure variability in chronic post-ischemic stroke. Clinics 73:e253. https://doi.org/10.6061/clinics/2018/e253CrossRefPubMedPubMedCentral

87.

Sykora M, Steiner T, Rocco A et al (2012) Baroreflex sensitivity to predict malignant middle cerebral artery infarction. Stroke 43:714–719. https://doi.org/10.1161/STROKEAHA.111.632778CrossRefPubMed

88.

Tsai WC, Lin HC, Lai YR et al (2019) The effect of stroke subtypes on baroreceptor sensitivity, a predict for acute stroke outcome. BioMed Res Int 2019:7614828. https://doi.org/10.1155/2019/7614828CrossRefPubMedPubMedCentral

89.

Malberg H, Wessel N, Hasart A, Osterziel KJ, Voss A (2002) Advanced analysis of spontaneous baroreflex sensitivity, blood pressure and heart rate variability in patients with dilated cardiomyopathy. Clin Sci 102:465–473. https://doi.org/10.1042/cs1020465CrossRef

90.

Chang Y, Chang W, Tsai N et al (2015) Link between cerebral blood flow and autonomic function in survivors of internal carotid artery occlusion. J Neurol Sci 353:143–148. https://doi.org/10.1016/j.jns.2015.04.035CrossRefPubMed

91.

Lin CH, Yen CC, Hsu Y et al (2019) Baroreceptor sensitivity predicts functional outcome and complications after acute ischemic stroke. J Clin Med 8:300. https://doi.org/10.3390/jcm8030300CrossRefPubMedPubMedCentral

92.

Lindsay J, Chesterton MK, Sigrist TB, Maarten W, McIntyre CW (2005) Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20:1140–1147. https://doi.org/10.1093/ndt/gfh808CrossRef

93.

De Vos A, De Keyser J, De Raedt S (2017) Role of infarct location and pre-existing depression on cardiac baroreceptor sensitivity in subacute ischemic stroke. Acta Neurol Belg 117:655–659. https://doi.org/10.1007/s13760-017-0814-7CrossRefPubMed

94.

Micieli G, Canavero I (2020) Autonomic dysfunction in acute stroke: mechanisms and possible treatments. Brain Heart Dyn. https://doi.org/10.1007/978-3-030-28008-6_33CrossRef

95.

Gkantzios A, Tsiptsios D, Karatzetzou S et al (2022) Stroke and emerging blood biomarkers: a clinical prospective. Neurol Int 14:784–803. https://doi.org/10.3390/neurolint14040065CrossRefPubMedPubMedCentral

96.

Cha KH, Kang NY, Huh S et al (2023) The effects of autonomic dysfunction on functional outcomes in patients with acute stroke. Brain Sci 13:1694. https://doi.org/10.3390/brainsci13121694CrossRefPubMedPubMedCentral

97.

Zis P, Vemmos K, Spengos K et al (2013) Ambulatory blood pressure monitoring in acute stroke: pathophysiology of the time rate of blood pressure variation and association with the 1-year outcome. Blood Pressure Monit 18:94–100. https://doi.org/10.1097/MBP.0b013e32835ebc3fCrossRef

98.

Koennecke HC, Belz W, Berfelde D et al (2011) Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 77:965–972. https://doi.org/10.1212/WNL.0b013e31822dc79CrossRefPubMed

99.

Maier IL, Becker JC, Leyhe JR et al (2018) Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. PLoS ONE 13:e0196174. https://doi.org/10.1371/journal.pone.0196174CrossRefPubMedPubMedCentral

100.

Westendorp WF, Dames C, Nederkoorn PJ, Meisel A (2022) Immunodepression, infections, and functional outcome in ischemic stroke. Stroke 53:1438–1448. https://doi.org/10.1161/STROKEAHA.122.038867CrossRefPubMed

101.

Zhao M, Guan L, Collet J, Wang Y (2020) Relationship between ischemic stroke locations, etiology subtypes, neurological outcomes, and autonomic cardiac function. Neurol Res 42:630–639. https://doi.org/10.1080/01616412.2020.1782103CrossRefPubMed

102.

Siepmann T, Ohle P, Sedghi A et al (2021) Randomized sham-controlled pilot study of neurocardiac function in patients with acute ischaemic stroke undergoing heart rate variability biofeedback. Front Neurol 12:669843. https://doi.org/10.3389/fneur.2021.669843CrossRefPubMedPubMedCentral

103.

Veldema J, Gharabaghi A (2022) Non-invasive brain stimulation for improving gait, balance and lower limbs motor function in stroke. J Neuro Eng Rehabil 19:1–24. https://doi.org/10.1186/s12984-022-01062-yCrossRef

104.

Larson M, Chantigian DP, Asirvatham-Jeyaraj N, Van de Winckel A, Keller-Ross ML (2020) Slow-paced breathing and autonomic function in people post-stroke. Front Physiol 11:573325. https://doi.org/10.3389/fphys.2020.573325CrossRefPubMedPubMedCentral

105.

Saway BF, Palmer C, Hughes C et al (2024) The evolution of neuromodulation for chronic stroke: from neuroplasticity mechanisms to brain-computer interfaces. Neurotherapeutics 21:e00337. https://doi.org/10.1016/j.neurot.2024.e00337CrossRefPubMedPubMedCentral

106.

Korupolu R, Miller A, Park A, Yozbatiran N (2024) Neurorehabilitation with vagus nerve stimulation: a systematic review. Front Neurol 15:1390217. https://doi.org/10.3389/fneur.2024.1390217CrossRefPubMedPubMedCentral

107.

Li L, Wang D, Pan H (2022) Non-invasive vagus nerve stimulation in cerebral stroke: current status and future perspectives. Front Neurosci 16:820665. https://doi.org/10.3389/fnins.2022.820665CrossRefPubMedPubMedCentral

108.

Wang M-H, Wang Y-X, Xie M et al (2024) Transcutaneous auricular vagus nerve stimulation with task-oriented training improves upper extremity function in patients with subacute stroke: a randomized clinical trial. Front Neurosci 18:1346634. https://doi.org/10.3389/fnins.2024.1346634CrossRefPubMedPubMedCentral

109.

Cheng K, Wang Z, Bai J, Xiong J, Chen J, Ni J (2022) Research advances in the application of vagus nerve electrical stimulation in ischemic stroke. Front Neurosci 16:1043446. https://doi.org/10.3389/fnins.2022.1043446CrossRefPubMedPubMedCentral

110.

Toffa D, Touma L, El Meskine T, Bouthillier A, Nguyen D (2020) Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: a critical review. Seizure 83:104–123. https://doi.org/10.1016/j.seizure.2020.09.027CrossRefPubMed

111.

Fournié C, Chouchou F, Dalleau G et al (2021) Heart rate variability biofeedback in chronic disease management: a systematic review. Complement Ther Med 60:102750. https://doi.org/10.1016/j.ctim.2021.102750CrossRefPubMed

112.

Caldwell YT, Steffen PR (2018) Adding HRV biofeedback to psychotherapy increases heart rate variability and improves the treatment of major depressive disorder. Int J Psychophysiol 131:96–101. https://doi.org/10.1016/j.ijpsycho.2018.01.001CrossRefPubMed

113.

Chang W-L, Lee J-T, Li C-R et al (2020) Effects of heart rate variability biofeedback in patients with acute ischemic stroke: a randomized controlled trial. Biol Res Nurs 22:34–44. https://doi.org/10.1177/1099800419881210CrossRefPubMed

114.

Winbo A, Paterson DJ (2020) The brain-heart connection in sympathetically triggered inherited arrhythmia syndromes. Heart Lung Circ 29:529–537. https://doi.org/10.1016/j.hlc.2019.11.002CrossRefPubMed

115.

Balla HZ, Cao Y, Ström JO (2021) Effect of beta-blockers on stroke outcome: a meta-analysis. Clin Epidemiol 13:225–236. https://doi.org/10.2147/CLEP.S268105CrossRefPubMedPubMedCentral

116.

Scanzano A, Cosentino M (2015) Adrenergic regulation of innate immunity: a review. Front Pharmacol 6:171. https://doi.org/10.3389/fphar.2015.00171CrossRefPubMedPubMedCentral

117.

Wang R, Köhrmann M, Kollmar R et al (2022) Cardiovascular medication seems to promote recovery of autonomic dysfunction after stroke. J Neurol 269:5454–5465. https://doi.org/10.1007/s00415-022-11204-wCrossRefPubMedPubMedCentral

118.

Wang R, Moeller S, Akhundova A et al (2023) Rapid recovery of poststroke cardiac autonomic dysfunction: Causes to be considered. Eur J Neurol 30:2488–2497. https://doi.org/10.1111/ene.15853CrossRefPubMed

119.

Lewandowski J, Symonides B, Gaciong Z, Sinski M (2015) The effect of statins on sympathetic activity: a meta-analysis. Clin Auton Res 25:125–131. https://doi.org/10.1007/s10286-015-0274-1CrossRefPubMedPubMedCentral

120.

Miller AJ, Arnold AC (2019) The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res 29:231–243. https://doi.org/10.1007/s10286-018-0572-5CrossRefPubMed

121.

Li C, Meng X, Pan Y et al (2021) The association between heart rate variability and 90-day prognosis in patients with transient ischemic attack and minor stroke. Front Neurol 12:636474. https://doi.org/10.3389/fneur.2021.636474CrossRefPubMedPubMedCentral

122.

Krafft P, McBride D, Rolland W, Lekic T, Flores J, Zhang J (2017) α7 nicotinic acetylcholine receptor stimulation attenuates neuroinflammation through JAK2-STAT3 activation in murine models of intracerebral hemorrhage. Biomed Res Int 1:8134653

123.

Han Z, Shen F, He Y et al (2014) Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. PLoS ONE 9:e105711. https://doi.org/10.1371/journal.pone.0152218CrossRefPubMedPubMedCentral

124.

Pavlov VA, Wang H, Czura CJ et al (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9:125–134CrossRefPubMedPubMedCentral

125.

Neumann S, Shields NJ, Balle T et al (2015) Innate immunity and inflammation post-stroke: an alpha7-nicotinic agonist perspective. Int J Mol Sci 16:29029–29046CrossRefPubMedPubMedCentral

Title: Autonomic dysfunction after stroke: an overview of recent clinical evidence and perspectives on therapeutic management
Authors: Anush Barkhudaryan
Wolfram Doehner
Nadja Jauert
Publication date: 25-03-2025
Publisher: Springer Berlin Heidelberg
Keywords: Stroke
Peripheral Nervous System Disease
Cerebral Ischemic Stroke
Intracranial Hemorrhage
Diagnostics in Neurology
Neurological Therapy
Cardiac Diagnostics
Published in: Clinical Autonomic Research
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-025-01120-0

How can you integrate PET into your practice? (Link opens in a new window)

Alzheimer Disease
Independent Medical Education

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:

Lilly

Developed by: Springer Healthcare IME

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now